Jun 28, 2019 08:00AM

Jun 25, 2019 04:44PM

Jun 4, 2019 08:34AM

Jun 4, 2019 08:30AM

May 29, 2019 08:37AM

May 29, 2019 08:30AM

Apr 23, 2019 12:01PM UPDATE -- AIT Therapeutics to Demonstrate NO Generator and Delivery System at Pediatric Academic Societies Meeting in Baltimore, MD on April 27-30

Apr 23, 2019 08:30AM

Feb 13, 2019 04:05PM

Feb 11, 2019 08:36AM

Feb 11, 2019 08:30AM

Feb 4, 2019 08:07AM

Feb 4, 2019 08:00AM

Jan 24, 2019 07:00AM AIT Enters into $32.5 million Commercial Licensing Agreement with Circassia Pharmaceuticals for Its Novel Nitric Oxide Generator and Delivery System for Use in the Hospital Setting in the United State

Jan 2, 2019 08:30AM

Dec 28, 2018 04:56PM

Nov 14, 2018 04:01PM

Sep 19, 2018 08:07AM

Sep 19, 2018 08:00AM

Aug 14, 2018 08:00AM

Aug 13, 2018 08:39AM AIT Therapeutics Inc. (AITB) Reports $20M Common Share Purchase Agreement with Lincoln Park Capital Fund

Aug 13, 2018 08:30AM

Jul 30, 2018 08:30AM

Jun 14, 2018 08:00AM

May 23, 2018 08:30AM

Mar 29, 2018 08:30AM

Mar 19, 2018 04:01PM

Feb 16, 2018 11:03AM AIT Therapeutics Announces $9.82 Million Private Placement

Jan 31, 2018 04:01PM

Jan 22, 2018 08:00AM

Nov 3, 2017 08:30AM

Nov 2, 2017 08:30AM

Nov 1, 2017 08:30AM

Oct 26, 2017 08:30AM

Oct 3, 2017 08:00AM AIT Therapeutics’ Inhaled Nitric Oxide Therapy Granted Orphan Drug Designation by the U.S. Food and Drug Administration for Treating Infections Caused by Nontuberculous Mycobacteria (NTM)

328,703 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All